|
Q4 2020
Filed on Feb 12, 2021
|
1,080
|
$61.45 - $80.38
$66.4K - $86.8K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
3,465
|
$3.32 - $4.76
$11.5K - $16.5K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
308
|
$35.07 - $42.82
$10.8K - $13.2K
|
|
|
Q4 2020
Filed on Feb 12, 2021
|
1,549
|
$45.3 - $51.62
$70.2K - $80K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
18,600
|
$5.41 - $11.02
$101K - $205K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
16,036
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
49,687
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
29,300
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
26,019
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
67,400
|
$2.0 - $2.34
$135K - $158K
|
|
Momenta Pharmaceuticals Inc
|
Q3 2020
Filed on Nov 13, 2020
|
258,812
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
79,467
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
63,900
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
5,409,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
14,200
|
N/A
|
|
Teva Pharmaceutical Fin LLC
|
Q3 2020
Filed on Nov 13, 2020
|
6,916,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
236,802
|
$9.87 - $12.05
$2.34M - $2.85M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
116,439
|
$3.98 - $8.33
$463K - $970K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
15,288
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
23,900
|
$45.92 - $60.92
$1.1M - $1.46M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
25,000
|
$6.18 - $7.65
$155K - $191K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
5,637
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
37,700
|
$14.05 - $16.48
$530K - $621K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
14,600
|
$15.23 - $21.84
$222K - $319K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
8,430,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
84,900
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
43,800
|
$15.81 - $20.94
$692K - $917K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
41,936
|
$65.11 - $84.85
$2.73M - $3.56M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
31,800
|
$11.73 - $16.25
$373K - $517K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
10,619
|
$1.04 - $1.28
$11K - $13.6K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
106,829
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
26,072
|
$1.34 - $7.28
$34.9K - $190K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
49,804
|
$146.02 - $169.56
$7.27M - $8.44M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
12,800
|
$8.32 - $10.44
$106K - $134K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
4,500,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
8,100
|
$66.65 - $81.23
$540K - $658K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
74,100
|
$41.04 - $59.64
$3.04M - $4.42M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
10,000,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
47,108
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
12,100
|
$61.81 - $114.86
$748K - $1.39M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
67,200
|
$3.59 - $4.58
$241K - $308K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
41,000
|
$5.59 - $7.04
$229K - $289K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
20,600
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
38,777
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
3,690,495
|
N/A
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
17,400
|
$59.07 - $90.11
$1.03M - $1.57M
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
11,400
|
$35.19 - $45.93
$401K - $524K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
2,800
|
$71.56 - $91.25
$200K - $256K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
12,285
|
$10.35 - $12.29
$127K - $151K
|
|
|
Q3 2020
Filed on Nov 13, 2020
|
24,100
|
N/A
|
|